2003Chinese Journal of Clinical Oncology and RehabilitationRequires access

Clinical observation on treatment of advanced non-small cell lung cancer with the regimen containing main- ly navelbine

Xie Zheng-qiang

Open publisher page 0 citations

Abstract

Objective To evaluate the efficacy and toxicity of NIP(NVB + IFO + DDP)regimen and NP (DDP+ NVB)regimen in treatment of non-small cell lung cancer(NSCLC). Methods Forty-eight cases of advanced NSCLC were randomly divided into NIP regimen group and NP regimen group. Results The results showed that the response rates of NIP group and NP group were 54.1% and 45.9% respectively, with no statistically significant difference between them( P 0.05) .The dose-limiting toxicity was neutropenia which was seen in all treated cases and 70.8% and 62.5% were grade III and grade IV inhibition in NIP group and NP group respectively. Gastric irritation was tolerable. Conclusion Both of these two regimens are effective and tolerable in the treatment of advanced NSCLC.The regimen of NVB,DDP plus IFO is better than NVB plus DDP. Although the former causes more severe toxic reaction, it can be tolerable.

About this research paper

What this paper is about

Objective To evaluate the efficacy and toxicity of NIP(NVB + IFO + DDP)regimen and NP (DDP+ NVB)regimen in treatment of non-small cell lung cancer(NSCLC). Methods Forty-eight cases of advanced NSCLC were randomly divided into NIP regimen group and NP regimen group. Results The results showed that the response rates of NIP group and NP group were 54.1% and 45.9% respectively, with no statistically significant difference between them( P 0.05) .The dose-limiting toxicity was neutropenia which was seen in all treated cases and 70.8% and 62.5% were grade III and grade IV inhibition in NIP group and NP group respectively. Gastric irritation was tolerable. Conclusion Both of these two regimens are effective and tolerable in the treatment of advanced NSCLC.The regimen of NVB,DDP plus IFO is better than NVB plus DDP. Although the former causes more severe toxic reaction, it can be tolerable.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the efficacy and toxicity of NIP(NVB + IFO + DDP)regimen and NP (DDP+ NVB)regimen in treatment of non-small cell lung cancer(NSCLC). Methods Forty-eight cases of advanced NSCLC were randomly divided into NIP regimen group and NP regimen group. Results The results showed that the response rates of NIP group and NP group were 54.1% and 45.9% respectively, with no statistically significant difference between them( P 0.05) .The dose-limiting toxicity was neutropenia which was seen in all treated cases and 70.8% and 62.5% were grade III and grade IV inhibition in NIP group and NP group respectively. Gastric irritation was tolerable. Conclusion Both of these two regimens are effective and tolerable in the treatment of advanced NSCLC.The regimen of NVB,DDP plus IFO is better than NVB plus DDP. Although the former causes more severe toxic reaction, it can be tolerable.

Key concepts: Regimen, Medicine, Lung cancer, Toxicity, Internal medicine, Neutropenia, NIP, Chemotherapy

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical observation on treatment of advanced non-small cell lung cancer with the regimen containing main- ly navelbine — Research Paper | ScholarLens